APELLIS PHARMACEUTICALS INC's ticker is and the CUSIP is 03753U906. A total of 3 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,924,976 | +572.9% | 944,400 | +1511.6% | 0.12% | +611.8% |
| Q2 2023 | $5,338,460 | -26.4% | 58,600 | -46.7% | 0.02% | -34.6% |
| Q1 2023 | $7,249,004 | +38.1% | 109,900 | +8.3% | 0.03% | +116.7% |
| Q4 2022 | $5,248,565 | +23.4% | 101,500 | +62.9% | 0.01% | +50.0% |
| Q3 2022 | $4,255,000 | +90.1% | 62,300 | +25.9% | 0.01% | +100.0% |
| Q2 2022 | $2,238,000 | +4.1% | 49,500 | +17.0% | 0.00% | +100.0% |
| Q1 2022 | $2,149,000 | +126.2% | 42,300 | +110.4% | 0.00% | +100.0% |
| Q4 2021 | $950,000 | -68.7% | 20,100 | -78.2% | 0.00% | -66.7% |
| Q3 2021 | $3,032,000 | -46.2% | 92,000 | +3.3% | 0.00% | -57.1% |
| Q2 2021 | $5,631,000 | +5.5% | 89,100 | -28.4% | 0.01% | -12.5% |
| Q1 2021 | $5,338,000 | +11.8% | 124,400 | +49.0% | 0.01% | 0.0% |
| Q4 2020 | $4,776,000 | +5585.7% | 83,500 | +2882.1% | 0.01% | – |
| Q3 2020 | $84,000 | -96.6% | 2,800 | -96.3% | 0.00% | -100.0% |
| Q2 2020 | $2,472,000 | +24.5% | 75,700 | +2.2% | 0.01% | -31.2% |
| Q1 2020 | $1,985,000 | +402.5% | 74,100 | +474.4% | 0.02% | +433.3% |
| Q4 2019 | $395,000 | – | 12,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PURA VIDA INVESTMENTS, LLC | 200,000 | $9,044,000 | 0.52% |
| GROUP ONE TRADING, L.P. | 49,500 | $2,238,000 | 0.00% |
| JANE STREET GROUP, LLC | 148,500 | $6,715,000 | 0.00% |
| SIMPLEX TRADING, LLC | 44,700 | $2,021,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |